Adverse event, n (%) | n = 906 |
---|---|
Cardiac disorders | 18 (2.0) |
  Atrioventricular block first degree | 1 (0.1) |
  Atrioventricular block second degree | 2 (0.2) |
  Bradycardia | 12 (1.3) |
  Palpitations | 1 (0.1) |
  Ventricular premature beats | 1 (0.1) |
  Sinus arrhythmia | 1 (0.1) |
Ear and labyrinth disorders | 2 (0.2) |
  Vertigo | 2 (0.2) |
Gastrointestinal disorders | 8 (0.9) |
  Diarrhoea | 2 (0.2) |
  Nausea | 5 (0.6) |
  Vomiting | 1 (0.1) |
General disorders and administration site conditions | 7 (0.8) |
  Asthenia | 4 (0.4) |
  Chest pain | 1 (0.1) |
  Chills | 1 (0.1) |
  Hyperpyrexia | 1 (0.1) |
  Malaise | 1 (0.1) |
Infections and infestations | 3 (0.3) |
Influenza | 1 (0.1) |
  Nasopharyngitis | 1 (0.1) |
  Urinary tract infection | 1 (0.1) |
Musculoskeletal and connective tissue disorders | 2 (0.2) |
  Pain in extremity | 2 (0.2) |
Nervous system disorders | 11 (1.2) |
  Dysgeusia | 1 (0.1) |
  Headache | 6 (0.7) |
  Paraesthesia | 1 (0.1) |
  Dizziness | 1 (0.1) |
  Neuralgia | 1 (0.1) |
  Somnolence | 2 (0.2) |
Eye disorders | 1 (0.1) |
  Vision blurred | 1 (0.1) |